The neurogenomics view of neurological diseases

JAMA Neurology

Volumn 70, Issue 6, 2013, Pages 689-694

  Tsuji, Shoji ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDASE;

AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOMICS; GLUCOCEREBROSIDASE GENE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN GENOME; MISSENSE MUTATION; MULTIPLE SCLEROSIS; NEUROGENOMICS; NEUROLOGIC DISEASE; PARKINSON DISEASE; PENETRANCE; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84878812746     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.734     Document Type: Review

References (91)

1. Trojanowski JQ, Vandeerstichele H, Korecka M, et al Alzheimer's Disease Neuroimaging Initiative. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement. 2010;6(3):230-238.
2. Gusella JF, Wexler NS, Conneally PM, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature. 1983;306(5940):234-238. (Pubitemid 14232350)
3. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72(6):971-983.
4. Koide R, Ikeuchi T, Onodera O, et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet. 1994;6(1):9-13.
5. Collins FS. Positional cloning: let's not call it reverse anymore. Nat Genet. 1992;1(1):3-6.
6. Collins FS. Positional cloning moves from perditional to traditional. Nat Genet. 1995;9(4):347-350.
7. Sato T, Miura M, Yamada M, et al. Severe neurological phenotypes of Q129 DR-PLA transgenic mice serendipitously created by en masse expansion of CAG repeats in Q76 DRPLA mice. Hum Mol Genet. 2009;18(4):723-736.
8. Suzuki K, Zhou J, Sato T, et al. DRPLA transgenic mouse substrains carrying single copy of full-length mutant human DRPLA gene with variable sizes of expanded CAG repeats exhibit CAG repeat length- and age-dependent changes in behavioral abnormalities and gene expression profiles. Neurobiol Dis. 2012;46(2):336-350.
9. Katsuno M, Adachi H, Kume A, et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 2002;35(5):843-854.
10. Mangiarini L, Sathasivam K, Seller M, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87(3):493-506. (Pubitemid 26374323)
11. Katsuno M, Banno H, Suzuki K, et al; Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): amulticentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9(9):875-884.
12. Sveinbjörnsdottir S, Hicks AA, Jonsson T, et al. Familial aggregation of Parkinson's disease in Iceland. N Engl J Med. 2000;343(24):1765-1770.
13. Fang F, Kamel F, Lichtenstein P, et al. Familial aggregation of amyotrophic lateral sclerosis. Ann Neurol. 2009;66(1):94-99.
14. Sanger F, Donelson JE, Coulson AR, Kössel H, Fischer D. Use of DNA polymerase I primed by a synthetic oligonucleotide to determine a nucleotide sequence in phage fl DNA. Proc Natl Acad Sci U S A. 1973;70(4):1209-1213.
15. Sanger F, Air GM, Barrell BG, et al. Nucleotide sequence of bacteriophage phi X174 DNA. Nature. 1977;265(5596):687-695. (Pubitemid 8039446)
16. Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet. 2010;11(1):31-46.
17. Tsuji S. Genetics of neurodegenerative diseases: insights from high-throughput resequencing. Hum Mol Genet. 2010;19(R1):R65-R70.
18. Okou DT, Steinberg KM, Middle C, Cutler DJ, Albert TJ, Zwick ME. Microarray-based genomic selection for high-throughput resequencing. Nat Methods. 2007;4(11):907-909. (Pubitemid 350042376)
19. Fayssoux RS, Tally W, Sanfilippo JA, et al. Spinal injuries after falls from hunting tree stands. Spine J. 2008;8(3):522-528. (Pubitemid 351608957)
20. Hodges E, Xuan Z, Balija V, et al. Genome-wide in situ exon capture for selective resequencing. Nat Genet. 2007;39(12):1522-1527. (Pubitemid 350191350)
21. Volpi L, Roversi G, Colombo EA, et al. Targeted next-generation sequencing appoints c16orf57 as clericuzio-type poikiloderma with neutropenia gene. Am J Hum Genet. 2010;86(1):72-76.
22. Hedges DJ, Burges D, Powell E, et al. Exome sequencing of a multigenerational human pedigree. PLoS One. 2009;4(12):e8232.
23. Zaghloul NA, Katsanis N. Functional modules, mutational load and human genetic disease. Trends Genet. 2010;26(4):168-176.
24. Biesecker LG. Exome sequencing makes medical genomics a reality. Nat Genet. 2010;42(1):13-14.
25. Ng SB, Buckingham KJ, Lee C, et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet. 2010;42(1):30-35.
26. Choi M, Scholl UI, Ji W, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A. 2009;106(45):19096-19101.
27. Ng SB, Turner EH, Robertson PD, et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature. 2009;461(7261):272-276.
28. Maher B. Exome sequencing takes centre stage in cancer profiling. Nature. 2009;459(7244):146-147.
29. Ng PC, Levy S, Huang J, et al. Genetic variation in an individual human exome. PLoS Genet. 2008;4(8):e1000160.
30. Ishiura H, Fukuda Y, Mitsui J, et al. Posterior column ataxia with retinitis pigmentosa in a Japanese family with a novel mutation in FLVCR1. Neurogenetics. 2011;12(2):117-121.
31. Ishiura H, Sako W, Yoshida M, et al. The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement. Am J Hum Genet. 2012;91(2):320-329.
32. Coppola G, Geschwind DH. Genomic medicine enters the neurology clinic. Neurology. 2012;79(2):112-114.
33. Sailer A, Scholz SW, Gibbs JR, et al. Exome sequencing in an SCA14 family demonstrates its utility in diagnosing heterogeneous diseases. Neurology. 2012;79(2):127-131.
34. Pierson TM, Adams DA, Markello T, et al NISC Comparative Sequencing Program. Exome sequencing as a diagnostic tool in a case of undiagnosed juvenile-onset GM1-gangliosidosis. Neurology. 2012;79(2):123-126.
35. Landouré G, Sullivan JM, Johnson JO, et al. Exome sequencing identifies a novel TRPV4 mutation in a CMT2C family. Neurology. 2012;79(2):192-194.
36. Schuster SC, Miller W, Ratan A, et al. Complete Khoisan and Bantu genomes from southern Africa. Nature. 2010;463(7283):943-947.
37. Bentley DR, Balasubramanian S, Swerdlow HP, et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature. 2008;456(7218):53-59.
38. Wang J, Wang W, Li R, et al. The diploid genome sequence of an Asian individual. Nature. 2008;456(7218):60-65.
39. Ahn SM, Kim TH, Lee S, et al. The first Korean genome sequence and analysis: full genome sequencing for a socio-ethnic group. Genome Res . 2009;19(9):1622-1629.
40. Wheeler DA, Srinivasan M, Egholm M, et al. The complete genome of an individual by massively parallel DNA sequencing. Nature. 2008;452(7189):872-876. (Pubitemid 351550870)
41. Li H, Ruan J, Durbin R. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res. 2008;18(11):1851-1858.
42. Li R, Li Y, Kristiansen K, Wang J. SOAP: short oligonucleotide alignment program. Bioinformatics. 2008;24(5):713-714. (Pubitemid 351321217)
43. Wang J, Mu Q. Soap-HT-BLAST: high throughput BLAST based on Web services. Bioinformatics. 2003;19(14):1863-1864. (Pubitemid 37220485)
44. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26(5):589-595.
45. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754-1760.
46. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexa-nucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245-256.
47. Eid J, Fehr A, Gray J, et al. Real-time DNA sequencing from single polymerase molecules. Science. 2009;323(5910):133-138.
48. Flusberg BA, Webster DR, Lee JH, et al. Direct detection of DNAmethylation during single-molecule, real-time sequencing. Nat Methods. 2010;7(6):461-465.
49. Olasagasti F, Lieberman KR, Benner S, et al. Replication of individual DNA molecules under electronic control using a protein nanopore. Nat Nanotechnol. 2010;5(11):798-806.
50. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A. 1984;81(11):3443-3446. (Pubitemid 14122690)
51. Gudbjartsson DF, Thorvaldsson T, Kong A, Gunnarsson G, Ingolfsdottir A. Allegro version 2. Nat Genet. 2005;37(10):1015-1016.
52. Fukuda Y, Nakahara Y, Date H, et al. SNP HiTLink: a high-throughput linkage analysis system employing dense SNP data. BMC Bioinformatics. 2009;10:121.
53. Wu CH, Fallini C, Ticozzi N, et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012;488(7412):499-503.
54. Doi H, Yoshida K, Yasuda T, et al. Exome sequencing reveals a homozygous SYT14 mutation in adult-onset, autosomal-recessive spinocerebellar ataxia with psychomotor retardation. Am J Hum Genet. 2011;89(2):320-327.
55. Ku CS, Naidoo N, Pawitan Y. Revisiting Mendelian disorders through exome sequencing. Hum Genet. 2011;129(4):351-370.
56. Suthers G, Laing N, Wilton S, Dorosz S, Waddy H. "Sporadic" motoneuron disease due to familial SOD1 mutation with low penetrance. Lancet. 1994;344(8939-8940):1773.
57. Murakami T, Warita H, Hayashi T, et al. A novel SOD1 gene mutation in familial ALS with low penetrance in females. J Neurol Sci. 2001;189(1-2):45-47. (Pubitemid 32776648)
58. Rezania K, Yan J, Dellefave L, et al. A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset, incomplete penetrance and a sensory neuropathy. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4(3):162-166. (Pubitemid 37184885)
59. Andersen PM, Restagno G, Stewart HG, Chiò A. Disease penetrance in amyotrophic lateral sclerosis associated with mutations in the SOD1 gene. Ann Neurol. 2004;55(2):298-299, author reply 299.
60. Nogales-Gadea G, Garcia-Arumi E, Andreu AL, Cervera C, Gamez J. A novel exon 5 mutation (N139H) in the SOD1 gene in a Spanish family associated with incomplete penetrance. J Neurol Sci. 2004;219(1-2):1-6. (Pubitemid 38405990)
61. Majounie E, Renton AE, Mok K, et al; Chromosome 9-ALS/FTD Consortium; French research network on FTLD/FTLD/ALS; ITALSGEN Consortium. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11(4):323-330.
62. Nozaki I, Hamaguchi T, Sanjo N, et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain. 2010;133(10):3043-3057.
63. Rosewich H, Thiele H, Ohlenbusch A, et al. Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study. Lancet Neurol. 2012;11(9):764-773.
64. Veeramah KR, O'Brien JE, Meisler MH, et al. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am J Hum Genet. 2012;90(3):502-510.
65. Awadalla P, Gauthier J, Myers RA, et al. Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet. 2010;87(3):316-324.
66. Rivière JB, van Bon BW, Hoischen A, et al. De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. Nat Genet. 2012;44(4):440-444, S1-S2.
67. Sasaki H, Emi M, Iijima H, et al. Copy number loss of (srchomology 2 domain containing)-transforming protein 2 (SHC2) gene: discordant loss in monozygotic twins and frequent loss in patients with multiple system atrophy. Mol Brain. 2011;4:24.
68. Baranzini SE, Mudge J, van Velkinburgh JC, et al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature. 2010;464(7293):1351-1356.
69. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet. 2001;17(9):502-510. (Pubitemid 32763048)
70. Collins FS, Guyer MS, Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science. 1997;278(5343):1580-1581. (Pubitemid 27516268)
71. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet. 2001;69(1):124-137. (Pubitemid 32614025)
72. Hindorff LA, Sethupathy P, Junkins HA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009;106(23):9362-9367.
73. Visscher PM. Sizing up human height variation. Nat Genet. 2008;40(5):489-490. (Pubitemid 351601227)
74. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747-753.
75. Satake W, Nakabayashi Y, Mizuta I, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet. 2009;41(12):1303-1307.
76. Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med. 2009;361(17):1651-1661.
77. Mitsui J, Mizuta I, Toyoda A, et al. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol. 2009;66(5):571-576.
78. Shino MY, McGuire V, Van Den Eeden SK, et al. Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study. Mov Disord. 2010;25(15):2587-2594.
79. Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E. Parkinsonism among Gaucher disease carriers. JMed Genet. 2004;41(12):937-940. (Pubitemid 40007255)
80. Neudorfer O, Giladi N, Elstein D, et al. Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM. 1996;89(9):691-694. (Pubitemid 26319021)
81. Kryukov GV, Pennacchio LA, Sunyaev SR. Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am J Hum Genet. 2007;80(4):727-739. (Pubitemid 46564409)
82. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68(4):820-823.
83. Bihaqi SW, Schumacher A, Maloney B, Lahiri DK, Zawia NH. Do epigenetic pathways initiate late onset Alzheimer disease (LOAD): towards a new paradigm. Curr Alzheimer Res. 2012;9(5):574-588.
84. Matsumoto L, Takuma H, Tamaoka A, et al. CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease. PLoS One. 2010;5(11):e15522.
85. Stöhr J, Watts JC, Mensinger ZL, et al. Purified and synthetic Alzheimer's amyloid beta (Aβ) prions. Proc Natl Acad Sci U S A. 2012;109(27):11025-11030.
86. de Calignon A, Polydoro M, Suárez-Calvet M, et al. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron. 2012;73(4):685-697.
87. Freeman JD, Warren RL, Webb JR, Nelson BH, Holt RA. Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing. Genome Res. 2009;19(10):1817-1824.
88. Warren RL, Freeman JD, Zeng T, et al. Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1million clonotypes. Genome Res. 2011;21(5):790-797.
89. Logan AC, Gao H, Wang C, et al. High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment. Proc Natl Acad Sci U S A . 2011;108(52):21194-21199.
90. Holcomb CL, Höglund B, Anderson MW, et al. A multi-site study using high-resolution HLA genotyping by next generation sequencing. Tissue Antigens. 2011;77(3):206-217.
91. Erlich RL, Jia X, Anderson S, et al. Next-generation sequencing for HLA typing of class I loci. BMC Genomics. 2011;12:42.